Jennifer A. Ligibel, MD, senior physician in the Breast Oncology Center at Dana-Farber Cancer Institute, Boston, Massachusetts, talks with Lindsay L. Peterson, MD, MSCR, about results from the Breast Cancer Weight Loss (BWEL) Trial, which tested the efficacy of a weight loss intervention on metabolic and inflammatory biomarkers in women with obesity and breast cancer.
▷ Estimated Read Time:
1–2 minutes
SABCS Snippets: Results from the Breast Cancer Weight Loss (BWEL) Trial
Connect with thousands of basic and translational scientists, multidisciplinary clinicians, regulatory and pharmaceutical partners, survivors, and patient advocates at the 49th annual San Antonio Breast Cancer Symposium. Complete your registration by Friday, September 25, to take advantage of discounted early registration rates.
Share: